Hook
We didn’t see this coming. Two weeks ago, Circle dropped $100M+—the exact figure is still hidden—to acquire about 1,000 blockchain patents from IBM. The market yawned. Shares of CRCL moved 2% pre-market. A dead cat bounce? Or the quiet start of something that will reshape stablecoin patent wars?
But the real question isn’t what Circle gained. It’s what Circle still lacks: a working business model that survives the Open USD alliance. Let me break down why this patent buy is a defensive airbag, not an engine upgrade.
Context
First, the backdrop. Circle is the issuer of USDC, the second-largest stablecoin by market cap. It’s a federally chartered trust bank under the OCC—a massive regulatory moat. But in 2026, that moat is under siege.
In June, the Open USD alliance launched. Backed by Visa, BlackRock, Stripe, and—ironically—IBM itself, Open USD offers a radically different value proposition: zero mint/redeem fees and pass-through of all reserve yield to distributors. No more sucking 3-4% off the top. The alliance has 140+ members. Visa’s stablecoin platform went live on July 16, giving Open USD an instant distribution network that Circle can only dream of.
Since its IPO at $31, CRCL hit $263 in late 2025. Then the Open USD news dropped. Shares collapsed to $63.60 as of Thursday. Analysts have cut ratings. Mizuho slashed 2027 EBITDA estimates by 18-24%. The average price target still sits at $120.76, implying massive potential upside—or delusion.
Core
Now, the patent acquisition. Circle bought a “core patent portfolio” covering foundational blockchain technologies, banking, financial services, supply chain verification, and secure cloud operations. Think of it as a mountain of granted patents that any competitor building in the same space must either license or risk litigation.
Let’s be precise: this is not innovation. IBM spent decades accumulating these patents through internal R&D, acquisitions, and partnerships. Circle simply wrote a check. The technical value added to USDC’s performance, security, or scalability is exactly zero. USDC remains a fully reserved, fiat-backed stablecoin. The patents don’t change its economics.
What they do change is the legal battlefield. Circle now holds the largest blockchain patent portfolio among US companies, possibly in the world. That gives them standing to sue—or threaten to sue—any new entrant that uses patented technology. Think of it as an exclusion zone: you can compete, but you must either pay a toll or risk an injunction.
But here’s the catch: Open USD doesn’t need to invent new blockchain tech. It’s built by a consortium that includes IBM as a partner. IBM contributed technology, but after selling the patents to Circle, IBM’s own legal position weakens. Circle could demand licensing fees from IBM’s Open USD clients. That’s the scenario the market hasn’t priced in.
However, the real elephant in the room is Circle’s core business problem: reserve yield. Circle made $2.86 billion in revenue over the past 12 months. Nearly all of it came from investing USDC reserves (mostly US Treasuries) and pocketing the yield. Open USD proposes to give that yield directly to distributors and users. If that model succeeds, Circle’s income stream vanishes.
Patents cannot restore reserve yield. Patents cannot win back distribution channels—especially Coinbase, which accounts for a huge chunk of USDC issuance and whose distribution agreement is up for renewal this quarter. Circle is negotiating now, but if Coinbase decides to integrate Open USD’s zero-fee structure, Circle loses its primary on-ramp.
Contrarian
Here’s where the conventional narrative stops—and where I start disagreeing.
Most analysts see the patent deal as a desperation move. I see a potential legal time bomb for Open USD. Let me explain.
IBM’s patent portfolio covers fundamental building blocks: UTXO-based smart contracts, cryptographic key management, cross-chain asset transfer mechanisms. If Open USD—or any of its member companies—uses these techniques without a license, Circle can file suit. And in US courts, patent owners historically win over 40% of their cases—even more when patents are already granted, not pending.
Imagine the scenario: Circle wins an injunction against Visa’s stablecoin platform, forcing Visa to either remove the feature or pay a royalty. That would instantly reset the competitive landscape. Circle could license the patent back to the alliance at a fraction of its original cost, turning a defensive asset into a revenue stream.
Is this likely? No. The probability is low—maybe 20-30%. But the market is pricing it at zero. That’s the asymmetric bet.
Another contrarian angle: regulatory tailwinds. Circle holds a national trust charter from the OCC. No other stablecoin issuer has that. If the US government tightens stablecoin oversight (as both parties now support), smaller issuers may exit, and new entrants (like Open USD) will face months of compliance delays. Circle’s portfolio of 1,000 patents becomes a strong signal to regulators: “We are the established, compliant leader.” Patents don’t fix cash flow, but they fix narrative.
Finally, there’s the compounding effect of patent peace. Circle can cross-license with other large patent holders (Ant Group, IBM, Microsoft) to reduce litigation risk. That’s a hidden option value that doesn’t appear on any balance sheet.
Takeaway
I’m not saying Circle is going to win. I’m saying the battle hasn’t been fought yet. The next 30 days are decisive: Circle’s August 5 earnings call will reveal the patent purchase price, any new licensing revenue, and—most importantly—the status of the Coinbase renewal. If Coinbase stays, Circle buys time. If Coinbase leaves, the stock will sink to $40 or below.
Watch the cash flow statement. Watch the intangible asset line. And watch the dockets of the US District Court for the Southern District of New York. The first patent lawsuit against Open USD—if it comes—will be the signal that this deal wasn’t about defense. It was about war.